Filtros : "FORLENZA, ORESTES VICENTE" "Talib, Leda L." Limpar

Filtros



Refine with date range


  • Source: International Psychogeriatrics. Unidade: FM

    Subjects: BIOMARCADORES, DOENÇA DE ALZHEIMER, COGNIÇÃO, AVALIAÇÃO EM SAÚDE, FLUÊNCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MIRANDEZ, Roberta M. et al. Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease. International Psychogeriatrics, v. 29, n. 6, p. 949-958, 2017Tradução . . Disponível em: https://doi.org/10.1017/S1041610217000102. Acesso em: 15 nov. 2024.
    • APA

      Mirandez, R. M., Aprahamian, I., Talib, L. L., & Forlenza, O. V. (2017). Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease. International Psychogeriatrics, 29( 6), 949-958. doi:10.1017/S1041610217000102
    • NLM

      Mirandez RM, Aprahamian I, Talib LL, Forlenza OV. Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease [Internet]. International Psychogeriatrics. 2017 ; 29( 6): 949-958.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1017/S1041610217000102
    • Vancouver

      Mirandez RM, Aprahamian I, Talib LL, Forlenza OV. Multiple category verbal fluency in mild cognitive impairment and correlation with CSF biomarkers for Alzheimer's disease [Internet]. International Psychogeriatrics. 2017 ; 29( 6): 949-958.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1017/S1041610217000102
  • Source: Bipolar Disorders. Unidade: FM

    Subjects: BIOMARCADORES, TRANSTORNO BIPOLAR, LÍQUIDO CEFALORRAQUIDIANO, DOENÇA DE ALZHEIMER

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FORLENZA, Orestes V. et al. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Bipolar Disorders, v. 18, n. 1, p. 63-70, 2016Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf. Acesso em: 15 nov. 2024.
    • APA

      Forlenza, O. V., Aprahamian, I., Radanovic, M., Talib, L. L., Camargo, M. Z. A., Stella, F., et al. (2016). Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Bipolar Disorders, 18( 1), 63-70. doi:10.1111/bdi.12360
    • NLM

      Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZA, Stella F, Machado-Vieira R, Gattaz WF. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid [Internet]. Bipolar Disorders. 2016 ; 18( 1): 63-70.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf
    • Vancouver

      Forlenza OV, Aprahamian I, Radanovic M, Talib LL, Camargo MZA, Stella F, Machado-Vieira R, Gattaz WF. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid [Internet]. Bipolar Disorders. 2016 ; 18( 1): 63-70.[citado 2024 nov. 15 ] Available from: http://onlinelibrary.wiley.com/doi/10.1111/bdi.12360/epdf
  • Source: Journal of Neural Transmission. Unidade: FM

    Subjects: EXPRESSÃO GÊNICA, DOENÇA DE ALZHEIMER, COGNIÇÃO (DEFICIÊNCIA)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GATTAZ, Wagner F. et al. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study. Journal of Neural Transmission, v. 121, n. 2, p. 193-200, 2014Tradução . . Disponível em: http://link.springer.com/article/10.1007/s00702-013-1088-8. Acesso em: 15 nov. 2024.
    • APA

      Gattaz, W. F., Talib, L. L., Schaeffer, E. L., Diniz, B. S., & Forlenza, O. V. (2014). Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study. Journal of Neural Transmission, 121( 2), 193-200. doi:10.1007/s00702-013-1088-8
    • NLM

      Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study [Internet]. Journal of Neural Transmission. 2014 ; 121( 2): 193-200.[citado 2024 nov. 15 ] Available from: http://link.springer.com/article/10.1007/s00702-013-1088-8
    • Vancouver

      Gattaz WF, Talib LL, Schaeffer EL, Diniz BS, Forlenza OV. Low platelet iPLA2 activity predicts conversion from mild cognitive impairment to Alzheimer’s disease: a 4-year follow-up study [Internet]. Journal of Neural Transmission. 2014 ; 121( 2): 193-200.[citado 2024 nov. 15 ] Available from: http://link.springer.com/article/10.1007/s00702-013-1088-8
  • Source: Journals of gerontology - Series B - Psychological sciences and social sciences. Unidade: FM

    Subjects: COGNIÇÃO, DEPRESSÃO, DOENÇA DE ALZHEIMER (LÍQUIDO CÉFALO-RAQUIDIANO)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Breno S. et al. Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression. Journals of gerontology - Series B - Psychological sciences and social sciences, v. 69, n. 6, p. 845-851, 2014Tradução . . Disponível em: https://doi.org/10.1093/geronb/gbu096. Acesso em: 15 nov. 2024.
    • APA

      Diniz, B. S., Teixeira, A. L., Machado-Vieira, R., Talib, L. L., Radanovic, M., Gattaz, W. F., & Forlenza, O. V. (2014). Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression. Journals of gerontology - Series B - Psychological sciences and social sciences, 69( 6), 845-851. doi:10.1093/geronb/gbu096
    • NLM

      Diniz BS, Teixeira AL, Machado-Vieira R, Talib LL, Radanovic M, Gattaz WF, Forlenza OV. Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression [Internet]. Journals of gerontology - Series B - Psychological sciences and social sciences. 2014 ; 69( 6): 845-851.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1093/geronb/gbu096
    • Vancouver

      Diniz BS, Teixeira AL, Machado-Vieira R, Talib LL, Radanovic M, Gattaz WF, Forlenza OV. Reduced Cerebrospinal Fluid Levels of Brain-Derived Neurotrophic Factor Is Associated With Cognitive Impairment in Late-Life Major Depression [Internet]. Journals of gerontology - Series B - Psychological sciences and social sciences. 2014 ; 69( 6): 845-851.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1093/geronb/gbu096
  • Source: Neuromolecular Medicine. Unidade: FM

    Subjects: DOENÇA DE ALZHEIMER, INFLAMAÇÃO, TRANSTORNOS COGNITIVOS, ADIPONECTINA (NÍVEL)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TEIXEIRA, Antonio L. et al. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease. Neuromolecular Medicine, v. 15, n. 1, p. 115-121, 2013Tradução . . Disponível em: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2. Acesso em: 15 nov. 2024.
    • APA

      Teixeira, A. L., Diniz, B. S., Campos, A. C., Miranda, A. S., Rocha, N. P., Talib, L. L., et al. (2013). Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease. Neuromolecular Medicine, 15( 1), 115-121. doi:10.1007%2Fs12017-012-8201-2
    • NLM

      Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2013 ; 15( 1): 115-121.[citado 2024 nov. 15 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2
    • Vancouver

      Teixeira AL, Diniz BS, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease [Internet]. Neuromolecular Medicine. 2013 ; 15( 1): 115-121.[citado 2024 nov. 15 ] Available from: http://link.springer.com/content/pdf/10.1007%2Fs12017-012-8201-2
  • Source: Prostaglandins, leukotrienes and essential fatty acids. Unidade: FM

    Subjects: FOSFOLIPÍDEOS, FOSFOLIPASES A (METABOLISMO), RADIOIMUNOENSAIO (ENZIMOLOGIA), PLAQUETAS SANGUÍNEAS, NEUROPSIQUIATRIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      TALIB, Leda L. et al. A radioenzymatic assay to identify three groups of phospholipase A2 in platelets. Prostaglandins, leukotrienes and essential fatty acids, v. 86, n. 4\20135, p. 149\2013153, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.plefa.2012.02.005. Acesso em: 15 nov. 2024.
    • APA

      Talib, L. L., Diniz, B. S., Zainaghi, I. A., Forlenza, O. V., & Gattaz, W. F. (2012). A radioenzymatic assay to identify three groups of phospholipase A2 in platelets. Prostaglandins, leukotrienes and essential fatty acids, 86( 4\20135), 149\2013153. doi:10.1016/j.plefa.2012.02.005
    • NLM

      Talib LL, Diniz BS, Zainaghi IA, Forlenza OV, Gattaz WF. A radioenzymatic assay to identify three groups of phospholipase A2 in platelets [Internet]. Prostaglandins, leukotrienes and essential fatty acids. 2012 ; 86( 4\20135): 149\2013153.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.plefa.2012.02.005
    • Vancouver

      Talib LL, Diniz BS, Zainaghi IA, Forlenza OV, Gattaz WF. A radioenzymatic assay to identify three groups of phospholipase A2 in platelets [Internet]. Prostaglandins, leukotrienes and essential fatty acids. 2012 ; 86( 4\20135): 149\2013153.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.plefa.2012.02.005
  • Source: Journal of Psychiatric Research. Unidade: FM

    Subjects: DEPRESSÃO (TERAPIA;ENZIMOLOGIA), PLAQUETAS SANGUÍNEAS, BIOMARCADORES, ANTIDEPRESSIVOS ( USO TERAPÊUTICO)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      JOAQUIM, Helena P. G. et al. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. Journal of Psychiatric Research, v. 46, n. 8, p. 1053-1058, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2012.04.020. Acesso em: 15 nov. 2024.
    • APA

      Joaquim, H. P. G., Talib, L. L., Forlenza, O. V., Diniz, B. S., & Gattaz, W. F. (2012). Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression. Journal of Psychiatric Research, 46( 8), 1053-1058. doi:10.1016/j.jpsychires.2012.04.020
    • NLM

      Joaquim HPG, Talib LL, Forlenza OV, Diniz BS, Gattaz WF. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 8): 1053-1058.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.04.020
    • Vancouver

      Joaquim HPG, Talib LL, Forlenza OV, Diniz BS, Gattaz WF. Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 8): 1053-1058.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.04.020
  • Source: Journal of Psychiatric Research. Unidade: FM

    Subjects: DEPRESSÃO (FISIOPATOLOGIA;DIAGNÓSTICO), SINAIS E SINTOMAS, IDOSOS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Breno S. et al. Circulating Glial-derived neurotrophic factor is reduced in late-life depression. Journal of Psychiatric Research, v. 46, n. 1, p. 135-139, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2011.09.007. Acesso em: 15 nov. 2024.
    • APA

      Diniz, B. S., Teixeira, A. L., Miranda, A. S., Talib, L. L., Gattaz, W. F., & Forlenza, O. V. (2012). Circulating Glial-derived neurotrophic factor is reduced in late-life depression. Journal of Psychiatric Research, 46( 1), 135-139. doi:10.1016/j.jpsychires.2011.09.007
    • NLM

      Diniz BS, Teixeira AL, Miranda AS, Talib LL, Gattaz WF, Forlenza OV. Circulating Glial-derived neurotrophic factor is reduced in late-life depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 1): 135-139.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2011.09.007
    • Vancouver

      Diniz BS, Teixeira AL, Miranda AS, Talib LL, Gattaz WF, Forlenza OV. Circulating Glial-derived neurotrophic factor is reduced in late-life depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 1): 135-139.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2011.09.007
  • Source: Journal of Psychiatric Research. Unidade: FM

    Subjects: DEPRESSÃO (FISIOPATOLOGIA), IDOSOS, BIOMARCADORES, ADIPONECTINA, DEPRESSÃO (PATOLOGIA), COGNIÇÃO, CITOCINAS (IMUNOLOGIA)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      DINIZ, Breno S. et al. Reduced serum levels of adiponectin in elderly patients with major depression. Journal of Psychiatric Research, v. 46, n. 8, p. 1053-1058, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.jpsychires.2012.04.028. Acesso em: 15 nov. 2024.
    • APA

      Diniz, B. S., Teixeira, A. L., Campos, A. C., Miranda, A. S., Rocha, N. P., Talib, L. L., et al. (2012). Reduced serum levels of adiponectin in elderly patients with major depression. Journal of Psychiatric Research, 46( 8), 1053-1058. doi:10.1016/j.jpsychires.2012.04.028
    • NLM

      Diniz BS, Teixeira AL, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Reduced serum levels of adiponectin in elderly patients with major depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 8): 1053-1058.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.04.028
    • Vancouver

      Diniz BS, Teixeira AL, Campos AC, Miranda AS, Rocha NP, Talib LL, Gattaz WF, Forlenza OV. Reduced serum levels of adiponectin in elderly patients with major depression [Internet]. Journal of Psychiatric Research. 2012 ; 46( 8): 1053-1058.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1016/j.jpsychires.2012.04.028
  • Source: The British journal of psychiatry. Unidade: FM

    Subjects: LÍTIO (TERAPIA;EFEITOS ADVERSOS), COGNIÇÃO (EFEITOS ADVERSOS)

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      FORLENZA, Orestes V. et al. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. The British journal of psychiatry, v. 198, n. 5, p. 351-356, 2011Tradução . . Disponível em: https://doi.org/10.1192/bjp.bp.110.080044. Acesso em: 15 nov. 2024.
    • APA

      Forlenza, O. V., Diniz, B. S., Radanovic, M., Santos, F. S., Talib, L. L., & Gattaz, W. F. (2011). Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. The British journal of psychiatry, 198( 5), 351-356. doi:10.1192/bjp.bp.110.080044
    • NLM

      Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial [Internet]. The British journal of psychiatry. 2011 ; 198( 5): 351-356.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1192/bjp.bp.110.080044
    • Vancouver

      Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial [Internet]. The British journal of psychiatry. 2011 ; 198( 5): 351-356.[citado 2024 nov. 15 ] Available from: https://doi.org/10.1192/bjp.bp.110.080044

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024